Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(1.24)
# 3,503
Out of 4,876 analysts
803
Total ratings
31%
Success rate
-12.87%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $27.01 | +277.64% | 33 | Jun 25, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $14 | $2.17 | +545.16% | 2 | Jun 25, 2025 | |
| KRYS Krystal Biotech | Reiterates: Buy | $240 | $139.70 | +71.80% | 31 | Jun 24, 2025 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $77 | $10.95 | +603.20% | 23 | Jun 24, 2025 | |
| LXRX Lexicon Pharmaceuticals | Reiterates: Buy | $4 | $0.89 | +349.44% | 22 | Jun 24, 2025 | |
| ATNM Actinium Pharmaceuticals | Reiterates: Buy | $4 | $1.59 | +152.37% | 31 | Jun 24, 2025 | |
| LCTX Lineage Cell Therapeutics | Reiterates: Buy | $9 | $0.98 | +822.23% | 12 | Jun 23, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $4 | $0.31 | +1,173.07% | 2 | Jun 18, 2025 | |
| CDTX Cidara Therapeutics | Assumes: Buy | $41 | $47.72 | -14.07% | 1 | Jun 18, 2025 | |
| ESPR Esperion Therapeutics | Reiterates: Buy | $16 | $1.05 | +1,431.10% | 29 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $2.48 | +141.94% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $4.49 | +479.30% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $21.02 | +137.87% | 35 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $5.52 | +189.86% | 20 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.29 | +675.19% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.44 | +802.78% | 31 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $5.13 | +582.93% | 9 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.56 | - | 4 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $27.37 | +280.05% | 24 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $1.92 | +368.75% | 15 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $2.22 | +665.77% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $10.82 | +195.83% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $15 | $0.45 | +3,248.21% | 15 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.43 | +1,018.88% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $5.18 | +4,726.25% | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $1.72 | +1,066.18% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $1.00 | +800.00% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.89 | +852.38% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 → $15 | $7.78 | +92.93% | 9 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.72 | +599.30% | 26 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.75 → $4.5 | $1.70 | +164.71% | 22 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.66 | +659.65% | 16 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $2.68 | +795.52% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $33.65 | +256.61% | 48 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $7.10 | +125.35% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.89 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $3.82 | +710.78% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.66 | +1,718.18% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.95 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $10.97 | +237.44% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.71 | +545.16% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $18.88 | +201.99% | 26 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $21 | $7.00 | +200.00% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.69 | +1,083.43% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.14 | +1,070.96% | 16 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.83 | +429.49% | 16 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $115.13 | - | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $1.87 | +1,290.37% | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.08 | +711.69% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.04 | +9,561.84% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.52 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $32 | $1.73 | +1,749.71% | 4 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $2.24 | +1,237.26% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.48 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $37.60 | -12.23% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $4.17 | +1,770.50% | 1 | Mar 24, 2017 |
Viking Therapeutics
Jun 25, 2025
Reiterates: Buy
Price Target: $102
Current: $27.01
Upside: +277.64%
Phio Pharmaceuticals
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $2.17
Upside: +545.16%
Krystal Biotech
Jun 24, 2025
Reiterates: Buy
Price Target: $240
Current: $139.70
Upside: +71.80%
Capricor Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $77
Current: $10.95
Upside: +603.20%
Lexicon Pharmaceuticals
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $0.89
Upside: +349.44%
Actinium Pharmaceuticals
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.59
Upside: +152.37%
Lineage Cell Therapeutics
Jun 23, 2025
Reiterates: Buy
Price Target: $9
Current: $0.98
Upside: +822.23%
Moleculin Biotech
Jun 18, 2025
Reiterates: Buy
Price Target: $4
Current: $0.31
Upside: +1,173.07%
Cidara Therapeutics
Jun 18, 2025
Assumes: Buy
Price Target: $41
Current: $47.72
Upside: -14.07%
Esperion Therapeutics
Jun 17, 2025
Reiterates: Buy
Price Target: $16
Current: $1.05
Upside: +1,431.10%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $2.48
Upside: +141.94%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $4.49
Upside: +479.30%
Jun 16, 2025
Reiterates: Buy
Price Target: $50
Current: $21.02
Upside: +137.87%
Jun 13, 2025
Reiterates: Buy
Price Target: $16
Current: $5.52
Upside: +189.86%
Jun 11, 2025
Reiterates: Buy
Price Target: $10
Current: $1.29
Upside: +675.19%
Jun 11, 2025
Reiterates: Buy
Price Target: $13
Current: $1.44
Upside: +802.78%
Jun 4, 2025
Reiterates: Buy
Price Target: $35
Current: $5.13
Upside: +582.93%
Jun 2, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.56
Upside: -
May 28, 2025
Reiterates: Buy
Price Target: $104
Current: $27.37
Upside: +280.05%
May 19, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $1.92
Upside: +368.75%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $2.22
Upside: +665.77%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $10.82
Upside: +195.83%
May 16, 2025
Maintains: Buy
Price Target: $21 → $15
Current: $0.45
Upside: +3,248.21%
May 15, 2025
Reiterates: Buy
Price Target: $16
Current: $1.43
Upside: +1,018.88%
May 13, 2025
Reiterates: Buy
Price Target: $250
Current: $5.18
Upside: +4,726.25%
May 9, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $1.72
Upside: +1,066.18%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $1.00
Upside: +800.00%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.89
Upside: +852.38%
Apr 30, 2025
Reiterates: Buy
Price Target: $11 → $15
Current: $7.78
Upside: +92.93%
Apr 28, 2025
Reiterates: Buy
Price Target: $40
Current: $5.72
Upside: +599.30%
Apr 25, 2025
Maintains: Buy
Price Target: $5.75 → $4.5
Current: $1.70
Upside: +164.71%
Apr 25, 2025
Reiterates: Buy
Price Target: $5
Current: $0.66
Upside: +659.65%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $2.68
Upside: +795.52%
Apr 21, 2025
Reiterates: Buy
Price Target: $120
Current: $33.65
Upside: +256.61%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $7.10
Upside: +125.35%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.89
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $3.82
Upside: +710.78%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.66
Upside: +1,718.18%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.95
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $10.97
Upside: +237.44%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.71
Upside: +545.16%
Mar 5, 2025
Reiterates: Buy
Price Target: $57
Current: $18.88
Upside: +201.99%
Feb 4, 2025
Maintains: Buy
Price Target: $8 → $21
Current: $7.00
Upside: +200.00%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.69
Upside: +1,083.43%
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $2.14
Upside: +1,070.96%
Dec 11, 2024
Reiterates: Buy
Price Target: $15
Current: $2.83
Upside: +429.49%
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $115.13
Upside: -
Nov 18, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $1.87
Upside: +1,290.37%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $3.08
Upside: +711.69%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.04
Upside: +9,561.84%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.52
Upside: -
Feb 25, 2021
Maintains: Buy
Price Target: $36 → $32
Current: $1.73
Upside: +1,749.71%
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $2.24
Upside: +1,237.26%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.48
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $37.60
Upside: -12.23%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $4.17
Upside: +1,770.50%